In 56 brain metastases from different cancer types, the prevalence of PTEN loss was very high in cases of lung and breast cancers, sometimes combining LOH and an inactivating mutation, suggesting that PTEN loss of function could contribute to brain metastatic processes [63]. The gene discussed is PTEN; the disease is cancer.